246 related articles for article (PubMed ID: 27324754)
1. Preface of EuPAT 7 Special Issue - Inventing Tomorrow's Development and Manufacturing.
Rantanen J; Khinast J
Eur J Pharm Sci; 2016 Jul; 90():1. PubMed ID: 27324754
[No Abstract] [Full Text] [Related]
2. Achieving continuous manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
Badman C; Trout BL
J Pharm Sci; 2015 Mar; 104(3):779-80. PubMed ID: 25501284
[No Abstract] [Full Text] [Related]
3. Emerging technologies supporting chemical process R&D and their increasing impact on productivity in the pharmaceutical industry.
Rubin AE; Tummala S; Both DA; Wang C; Delaney EJ
Chem Rev; 2006 Jul; 106(7):2794-810. PubMed ID: 16836299
[No Abstract] [Full Text] [Related]
4. Synthetic peptide API manufacturing: A mini review of current perspectives for peptide manufacturing.
Rasmussen JH
Bioorg Med Chem; 2018 Jun; 26(10):2914-2918. PubMed ID: 29735426
[No Abstract] [Full Text] [Related]
5. Control systems engineering in continuous pharmaceutical manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
Myerson AS; Krumme M; Nasr M; Thomas H; Braatz RD
J Pharm Sci; 2015 Mar; 104(3):832-9. PubMed ID: 25546650
[TBL] [Abstract][Full Text] [Related]
6. Second-Generation Pharmaceutical Proteins-EUFEPS Workshop on Optimizing Biotech Medicines.
Pasut G; Veronese FM
IDrugs; 2007 Mar; 10(3):162-4. PubMed ID: 17351866
[No Abstract] [Full Text] [Related]
7. Regulatory and quality considerations for continuous manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
Allison G; Cain YT; Cooney C; Garcia T; Bizjak TG; Holte O; Jagota N; Komas B; Korakianiti E; Kourti D; Madurawe R; Morefield E; Montgomery F; Nasr M; Randolph W; Robert JL; Rudd D; Zezza D
J Pharm Sci; 2015 Mar; 104(3):803-12. PubMed ID: 25830179
[TBL] [Abstract][Full Text] [Related]
8. Achieving continuous manufacturing: technologies and approaches for synthesis, workup, and isolation of drug substance. May 20-21, 2014 Continuous Manufacturing Symposium.
Baxendale IR; Braatz RD; Hodnett BK; Jensen KF; Johnson MD; Sharratt P; Sherlock JP; Florence AJ
J Pharm Sci; 2015 Mar; 104(3):781-91. PubMed ID: 25470351
[TBL] [Abstract][Full Text] [Related]
9. Achieving continuous manufacturing for final dosage formation: challenges and how to meet them. May 20-21, 2014 Continuous Manufacturing Symposium.
Byrn S; Futran M; Thomas H; Jayjock E; Maron N; Meyer RF; Myerson AS; Thien MP; Trout BL
J Pharm Sci; 2015 Mar; 104(3):792-802. PubMed ID: 25501530
[TBL] [Abstract][Full Text] [Related]
10. How development and manufacturing will need to be structured--heads of development/manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
Nepveux K; Sherlock JP; Futran M; Thien M; Krumme M
J Pharm Sci; 2015 Mar; 104(3):850-64. PubMed ID: 25630721
[TBL] [Abstract][Full Text] [Related]
11. Industrially feasible alternative approaches in the manufacture of solid dispersions: a technical report.
Karanth H; Shenoy VS; Murthy RR
AAPS PharmSciTech; 2006 Oct; 7(4):87. PubMed ID: 17233539
[TBL] [Abstract][Full Text] [Related]
12. In biomarkers we trust?
Baker M
Nat Biotechnol; 2005 Mar; 23(3):297-304. PubMed ID: 15765081
[No Abstract] [Full Text] [Related]
13. Future supply chains enabled by continuous processing--opportunities and challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
Srai JS; Badman C; Krumme M; Futran M; Johnston C
J Pharm Sci; 2015 Mar; 104(3):840-9. PubMed ID: 25631279
[TBL] [Abstract][Full Text] [Related]
14. Theme issue "Solid state and solid dosage forms".
Kleinebudde P
Eur J Pharm Biopharm; 2009 Jan; 71(1):1. PubMed ID: 18817869
[No Abstract] [Full Text] [Related]
15. Equipment and analytical companies meeting continuous challenges. May 20-21, 2014 Continuous Manufacturing Symposium.
Page T; Dubina H; Fillipi G; Guidat R; Patnaik S; Poechlauer P; Shering P; Guinn M; Mcdonnell P; Johnston C
J Pharm Sci; 2015 Mar; 104(3):821-31. PubMed ID: 25448273
[TBL] [Abstract][Full Text] [Related]
16. White paper on continuous bioprocessing. May 20-21, 2014 Continuous Manufacturing Symposium.
Konstantinov KB; Cooney CL
J Pharm Sci; 2015 Mar; 104(3):813-20. PubMed ID: 25417595
[TBL] [Abstract][Full Text] [Related]
17. The future of pharmaceutical manufacturing in the context of the scientific, social, technological and economic evolution.
Stegemann S
Eur J Pharm Sci; 2016 Jul; 90():8-13. PubMed ID: 26542345
[TBL] [Abstract][Full Text] [Related]
18. Private company profiles.
Nat Biotechnol; 2002 Jul; 20 Suppl():BE15-21. PubMed ID: 12089572
[No Abstract] [Full Text] [Related]
19. Emerging technology: A key enabler for modernizing pharmaceutical manufacturing and advancing product quality.
O'Connor TF; Yu LX; Lee SL
Int J Pharm; 2016 Jul; 509(1-2):492-498. PubMed ID: 27260134
[TBL] [Abstract][Full Text] [Related]
20. Target selection and pharma industry productivity: what can we learn from technology S-curve theory?
Brown D
Curr Opin Drug Discov Devel; 2006 Jul; 9(4):414-8. PubMed ID: 16889225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
